-
2
-
-
0000581232
-
State of the art in the treatment of gastric cancer: From the 71st Japanese Gastric Cancer Congress
-
Fujii M, Sasaki J, Nakajima T: State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2:151-157.
-
(1999)
Gastric Cancer
, vol.2
, pp. 151-157
-
-
Fujii, M.1
Sasaki, J.2
Nakajima, T.3
-
3
-
-
0027248855
-
Adjuvant therapy after curative resection for gastric cancer: Meta analysis of randomized trials
-
Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama S, Sasako M, Velde CJH: Adjuvant therapy after curative resection for gastric cancer: meta analysis of randomized trials. J Clin Oncol 1993; 11:1441-1447.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1441-1447
-
-
Hermans, J.1
Bonenkamp, J.J.2
Boon, M.C.3
Bunt, A.M.G.4
Ohyama, S.5
Sasako, M.6
Velde, C.J.H.7
-
4
-
-
0033231084
-
Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of Western and Oriental trials
-
Shimada K, Ajani JA: Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of Western and Oriental trials. Cancer 1999; 86:1657-1668.
-
(1999)
Cancer
, vol.86
, pp. 1657-1668
-
-
Shimada, K.1
Ajani, J.A.2
-
5
-
-
0024447158
-
Preoperative chemotherapy in locally advanced and non-resectable gastric cancer: A phase II study with etoposide, doxorubicin and cisplatin
-
Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ Meyer J, Siewert JR, Achterrath W, Lenaz L, Knipp H, Schmoll HJ: Preoperative chemotherapy in locally advanced and non-resectable gastric cancer: a phase II study with etoposide, doxorubicin and cisplatin. J Clin Oncol 1989; 7:1318-1326.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1318-1326
-
-
Wilke, H.1
Preusser, P.2
Fink, U.3
Gunzer, U.4
Meyer, H.J.5
Meyer, J.6
Siewert, J.R.7
Achterrath, W.8
Lenaz, L.9
Knipp, H.10
Schmoll, H.J.11
-
6
-
-
0020460589
-
Clinical cancer research: An embattled species
-
Frei E: Clinical cancer research: An embattled species. Cancer 1982; 50:1979-1992.
-
(1982)
Cancer
, vol.50
, pp. 1979-1992
-
-
Frei, E.1
-
7
-
-
0020583556
-
Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases
-
Fisher B, Gunduz N, Saffer EA: Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983; 43:1488-1492.
-
(1983)
Cancer Res
, vol.43
, pp. 1488-1492
-
-
Fisher, B.1
Gunduz, N.2
Saffer, E.A.3
-
8
-
-
0027456689
-
Neoadjuvant chemotherapy for high-grade advanced gastric cancer
-
Yonemura Y, Sawa T, Kinoshita K, Matsuki N, Fushida S, Tanaka S, Miyazaki I: Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 1993; 17:256-262.
-
(1993)
World J Surg
, vol.17
, pp. 256-262
-
-
Yonemura, Y.1
Sawa, T.2
Kinoshita, K.3
Matsuki, N.4
Fushida, S.5
Tanaka, S.6
Miyazaki, I.7
-
9
-
-
0033119140
-
Chemotherapy for operable gastric cancer: Results of the Dutch randomized FAMTX trial
-
Songun I, Keizer HJ, Hermans J, Klementschitsch P, Vries JE, Wiles JA, Bijl J Krieken JHJM, Velde CJH: Chemotherapy for operable gastric cancer: Results of the Dutch randomized FAMTX trial. Eur J Cancer 1999; 35:558-562.
-
(1999)
Eur J Cancer
, vol.35
, pp. 558-562
-
-
Songun, I.1
Keizer, H.J.2
Hermans, J.3
Klementschitsch, P.4
Vries, J.E.5
Wiles, J.A.6
Bijl, J.7
Krieken, J.H.J.M.8
Velde, C.J.H.9
-
10
-
-
1442292040
-
Pharmacokinetics (PK) and efficacy of S-1 plus Cisplatin (CDDP) in patients with advanced gastric cancer (GC): A phase I/II study
-
Koizumi W, Tanabe S, Saigenjl K, Ohtsu A, Boku N, Nagashima F, Muto M: Pharmacokinetics (PK) and efficacy of S-1 plus Cisplatin (CDDP) in patients with advanced gastric cancer (GC): A phase I/II study, 11th NCI-EORTC-AACR symposium on new drugs in cancer therapy. Procedure. Nov. 2000:537.
-
(2000)
11th NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy. Procedure. Nov.
, pp. 537
-
-
Koizumi, W.1
Tanabe, S.2
Saigenjl, K.3
Ohtsu, A.4
Boku, N.5
Nagashima, F.6
Muto, M.7
-
11
-
-
0003192645
-
Japanese classification of gastric carcinoma - 2nd English Edition
-
Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer 1998; 1:10-24.
-
(1998)
Gastric Cancer
, vol.1
, pp. 10-24
-
-
-
12
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Glabbeke MV, Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. JNCI 2000; 92:205-216.
-
(2000)
JNCI
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Glabbeke, M.V.8
Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
13
-
-
0026348878
-
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy
-
Ajani JA, Ota DM, Jessup M, Ames FC, McBride C, Boddie A, Levin B, Jackson DE, Roh M, Hohn D: Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 1991; 68:1501-1506.
-
(1991)
Cancer
, vol.68
, pp. 1501-1506
-
-
Ajani, J.A.1
Ota, D.M.2
Jessup, M.3
Ames, F.C.4
McBride, C.5
Boddie, A.6
Levin, B.7
Jackson, D.E.8
Roh, M.9
Hohn, D.10
-
14
-
-
0028073098
-
Neoadjuvant chemotherapy in locally advanced gastric carcinoma-a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum
-
Rougier P, Mahjoubi M, Lasser P, Ducreux M, Oliveira J, Ychou M, Pignon JP, Elias D, Bellefqih S, Bognel C, Lusinchi A, Cvitkovic E, Droz Jp: Neoadjuvant chemotherapy in locally advanced gastric carcinoma-a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. Eur J Cancer 1994; 30A:1269-1275.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 1269-1275
-
-
Rougier, P.1
Mahjoubi, M.2
Lasser, P.3
Ducreux, M.4
Oliveira, J.5
Ychou, M.6
Pignon, J.P.7
Elias, D.8
Bellefqih, S.9
Bognel, C.10
Lusinchi, A.11
Cvitkovic, E.12
Droz, Jp.13
-
15
-
-
0029044328
-
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction
-
Ajani JA, Roth JA, Putnam JB, Walsh G, Lynch PM, Roubein LD, Ryan MB, Natrajan G, Gould P: Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction. Eur J Cancer 1995; 31A:665-670.
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 665-670
-
-
Ajani, J.A.1
Roth, J.A.2
Putnam, J.B.3
Walsh, G.4
Lynch, P.M.5
Roubein, L.D.6
Ryan, M.B.7
Natrajan, G.8
Gould, P.9
-
16
-
-
0029902878
-
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
-
Melcher AA, Mort D, Maughan TS: Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br J Cancer 1996; 74:1651-1654.
-
(1996)
Br J Cancer
, vol.74
, pp. 1651-1654
-
-
Melcher, A.A.1
Mort, D.2
Maughan, T.S.3
-
17
-
-
8944230186
-
Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil
-
Kelsen D, Karpeh M, Schwartz G, Gerdes H, Iightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M: Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 1996; 14:1818-1828.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1818-1828
-
-
Kelsen, D.1
Karpeh, M.2
Schwartz, G.3
Gerdes, H.4
Iightdale, C.5
Botet, J.6
Lauers, G.7
Klimstra, D.8
Huang, Y.9
Saltz, L.10
Quan, V.11
Brennan, M.12
-
18
-
-
0030911981
-
Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: A final report
-
Crookes P, Leichman CG, Leichman L, Tan M, Laine L, Stain S, Baranda J, Casagrande Y, Groshen S, Siberman H: Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer 1997; 79:1767-1775.
-
(1997)
Cancer
, vol.79
, pp. 1767-1775
-
-
Crookes, P.1
Leichman, C.G.2
Leichman, L.3
Tan, M.4
Laine, L.5
Stain, S.6
Baranda, J.7
Casagrande, Y.8
Groshen, S.9
Siberman, H.10
-
19
-
-
0342948592
-
Neoadjuvant chemotherapy with P-ELF (Cisplatin, Etoposide, Leucovorin, 5-Fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: A phase II study
-
Gallardo-Rincon D, Onate-Ocana LF, Calderillo-Ruiz G: Neoadjuvant chemotherapy with P-ELF (Cisplatin, Etoposide, Leucovorin, 5-Fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 2000; 7:45-50.
-
(2000)
Ann Surg Oncol
, vol.7
, pp. 45-50
-
-
Gallardo-Rincon, D.1
Onate-Ocana, L.F.2
Calderillo-Ruiz, G.3
-
20
-
-
0026560221
-
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: Results of a phase II trial
-
Lerner A, Gonin R, Steele GD Jr: Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol 1992; 10:536-540.
-
(1992)
J Clin Oncol
, vol.10
, pp. 536-540
-
-
Lerner, A.1
Gonin, R.2
Steele Jr., G.D.3
-
21
-
-
9344248389
-
Antitumor activity of 1 M tegaful-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats
-
Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fukushima M: Antitumor activity of 1 M tegaful-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 1996; 56:2602-2606.
-
(1996)
Cancer Res
, vol.56
, pp. 2602-2606
-
-
Shirasaka, T.1
Nakano, K.2
Takechi, T.3
Satake, H.4
Uchida, J.5
Fukushima, M.6
-
22
-
-
0032819756
-
An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers
-
Sugimachi K, Maehara Y, Horikoshi N, Shimada Y, Sakata Y, Mitachi Y: An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. Oncology 1999; 57:202-210.
-
(1999)
Oncology
, vol.57
, pp. 202-210
-
-
Sugimachi, K.1
Maehara, Y.2
Horikoshi, N.3
Shimada, Y.4
Sakata, Y.5
Mitachi, Y.6
-
23
-
-
0032189218
-
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients
-
SakataY, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998; 34:1715-1720.
-
(1998)
Eur J Cancer
, vol.34
, pp. 1715-1720
-
-
Sakata, Y.1
Ohtsu, A.2
Horikoshi, N.3
Sugimachi, K.4
Mitachi, Y.5
Taguchi, T.6
-
24
-
-
0000889107
-
A phase I/II study of S-1 plus cisplatin (CDDP) in patients (pts) with advanced gastric cancer (AGC)
-
Ohtsu A, Boku N, Nagashima F, Koizumi W, Tanabe S, Saigenji K, Muro K, Matsumura Y, Shirao K: A phase I/II study of S-1 plus cisplatin (CDDP) in patients (pts) with advanced gastric cancer (AGC). Proceeding of ASCO 2001; 20:165a.
-
(2001)
Proceeding of ASCO
, vol.20
-
-
Ohtsu, A.1
Boku, N.2
Nagashima, F.3
Koizumi, W.4
Tanabe, S.5
Saigenji, K.6
Muro, K.7
Matsumura, Y.8
Shirao, K.9
-
25
-
-
0033498239
-
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer
-
Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA: Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999; 229:303-308.
-
(1999)
Ann Surg
, vol.229
, pp. 303-308
-
-
Lowy, A.M.1
Mansfield, P.F.2
Leach, S.D.3
Pazdur, R.4
Dumas, P.5
Ajani, J.A.6
|